Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy?

Figure 1

Postoperative whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma. *30-Gy in fractions with a 15-Gy boost.